Science 37 Provides Fully Consented Patients to Sites to Supplement Enrollment
April 17, 2024 08:00 ET
|
Science 37, Inc.
Science 37's Patient Recruitment Solution provides fully-consented patients to clinical trial sites to supplement enrollment.
Science 37 to be Acquired by eMed, Expanding Access to Patients and Accelerating Enrollment
January 29, 2024 07:30 ET
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE) (the “Company” or “Science 37”), the clinical research industry’s leading MetasiteTM, today...
Science 37 Receives Top Honors in Everest PEAK Matrix®
December 12, 2023 08:00 ET
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., Dec. 12, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the clinical research industry-leading Metasite™ today announced that it has been named a...
Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
December 07, 2023 16:59 ET
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., Dec. 07, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™, today announced the granting of inducement equity awards...
Science 37 Holdings, Inc. Announces 1-for-20 Reverse Stock Split effective December 8, 2023
December 05, 2023 07:00 ET
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., Dec. 05, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE) (“Science 37” or the “Company”), the clinical research industry-leading Metasite™, announced...
Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
November 10, 2023 16:39 ET
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™, today announced the granting of inducement equity awards...
Science 37 Reports Third Quarter 2023 Financial Results
November 07, 2023 06:00 ET
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), (“Science 37”), the industry-leading Metasite™, today reported its financial results for the...
Science 37 to Report Third Quarter 2023 Financial Results on November 7, 2023
October 24, 2023 06:00 ET
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™ today announced it will report third quarter 2023 financial...
Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
October 06, 2023 16:41 ET
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., Oct. 06, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™, today announced the granting of inducement equity awards...
Science 37 Chief Delivery Officer, Darcy Forman, Named to Prestigious PharmaVoice 100 List
September 20, 2023 07:59 ET
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the clinical research industry-leading Metasite™, today announced that its Chief Delivery...